The efficacy of transmucosal fentanyl as an analgesic agent during peripheral retinal laser photocoagulation.

Trial Profile

The efficacy of transmucosal fentanyl as an analgesic agent during peripheral retinal laser photocoagulation.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Oct 2011

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Procedural pain
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms Transmucosal fentanyl analgesia in retinal photocoagulation
  • Most Recent Events

    • 19 Oct 2011 Additional location (England) added as reported by ClinicalTrials.gov.
    • 19 Oct 2011 Additional lead trial centre identified as reported by ISRCTN: Current Controlled Trials record.
    • 19 Oct 2011 Planned Eed date changed from 1 Aug 2007 to 1 Dec 2007 as reported by ISRCTN: Current Controlled Trials record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top